G01N 2333/9643
With ec number
Official title: with EC number
G01N2333/9643 (With ec number) appears on 1,083 US grants and 1,639 published applications in this corpus.
Search patents in G01N- Granted patents
- 1,083
- Published applications
- 1,639
- Assignees
- 941
- Inventors
- 3,495
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 2 | 0 |
| 1979 | 2 | 0 |
| 1980 | 2 | 0 |
| 1981 | 4 | 0 |
| 1982 | 4 | 0 |
| 1983 | 2 | 0 |
| 1984 | 4 | 0 |
| 1985 | 1 | 0 |
| 1986 | 2 | 0 |
| 1987 | 3 | 0 |
| 1988 | 3 | 0 |
| 1989 | 9 | 0 |
| 1990 | 5 | 0 |
| 1991 | 6 | 0 |
| 1992 | 4 | 0 |
| 1993 | 6 | 0 |
| 1994 | 11 | 0 |
| 1995 | 12 | 0 |
| 1996 | 14 | 0 |
| 1997 | 33 | 0 |
| 1998 | 52 | 0 |
| 1999 | 28 | 0 |
| 2000 | 33 | 0 |
| 2001 | 31 | 8 |
| 2002 | 26 | 40 |
| 2003 | 20 | 77 |
| 2004 | 26 | 51 |
| 2005 | 22 | 43 |
| 2006 | 33 | 47 |
| 2007 | 19 | 54 |
| 2008 | 20 | 37 |
| 2009 | 19 | 56 |
| 2010 | 29 | 73 |
| 2011 | 29 | 64 |
| 2012 | 25 | 69 |
| 2013 | 31 | 66 |
| 2014 | 49 | 62 |
| 2015 | 50 | 114 |
| 2016 | 25 | 118 |
| 2017 | 45 | 75 |
| 2018 | 40 | 71 |
| 2019 | 52 | 77 |
| 2020 | 50 | 72 |
| 2021 | 43 | 58 |
| 2022 | 37 | 67 |
| 2023 | 33 | 63 |
| 2024 | 26 | 67 |
| 2025 | 34 | 56 |
| 2026 | 25 | 54 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Methods for detection of pathogenic antiphospholipid antibodies and for identification of inhibitors29 Sep 2026US 12,748,111 B2The Scripps Research Institute
- Kits22 Sep 2026US 12,742,779 B1Takeda Pharmaceutical Company Limited
- Equine multiplex health information panel22 Sep 2026US 12,742,788 B1Boundless Diagnostics Inc
- Heparin-insensitive assay for factor XIa25 Aug 2026US 12,716,084 B2Takeda Pharmaceutical Company Limited
- Monoclonal antibody against human activated protein C and preparation and use thereof18 Aug 2026US 12,708,662 B2Oklahoma Medical Research Foundation
- Electrochemical biosensors, systems, and methods of use8 Oct 2026US 2026/0309671 A1
- Tau assay8 Oct 2026US 2026/0309720 A1
- Compositions for use in the treatment of endometriosis24 Sep 2026US 2026/0286008 A1Yeda Research and Development Co. Ltd.
- Peptide substrates and inhibitors of cathepsin b10 Sep 2026US 2026/0265298 A1The Regents of the University of California
- Oligonucleotide Modulators Activating Factor VII Expression and Use Thereof in Treatment of Hemophilia10 Sep 2026US 2026/0265739 A1
Most cited
By later US patents
- Methods for identifying nucleic acid ligands856US 5,270,163 AUniversity Research Corporation · 1993
- Nucleic acid ligands561US 5,475,096 AUniversity Research Corporation · 1995
- Systematic evolution of ligands by exponential enrichment: Solution SELEX337US 5,567,588 AUniversity Research Corporation · 1996
- Systematic evolution of ligands by exponential enrichment: chimeric selex281US 5,637,459 ANeXstar Pharmaceuticals, Inc. · 1997
- High-affinity nucleic acid ligands that discriminate between theophylline and caffeine277US 5,580,737 ANeXstar Pharmaceuticals, Inc. · 1996